Untitled Document
2018 FoundersDay Hero Image

Distinguished Alumni Award Honorees


Friedman

Joann L. Data, MD ‘70

Senior Consultant, Clinical and Regulatory Affairs
DATA CONSULTING

 

Before launching her own independent drug development consulting company in 2006, Joann Data served the pharmaceutical industry for nearly three decades. During that time, she assisted in the development and approval of 39 new drugs in a variety of therapeutic areas.

In 1976, Data began her pharmaceu​tical career with the Upjohn Co., where she held several positions. Following the merger of Upjohn and Pharmacia in 1996, she changed her career path, entering the biotechnology arena. After various roles at CoCensys and Cortex in Orange County, California, she moved to Amylin Pharmaceuticals in San Diego in 1999. As senior vice president of regulatory affairs and quality assurance, Data was instrumental in the approval of two diabetes drugs within six weeks in early 2005. She later served as senior vice president of corporate assignments during Amylin’s transition to a market-based company. From 2001 to 2008, she was a director on the board of Nventa Biopharmaceuticals Corp.

After retiring from Amylin, Data started her own business, Data Consulting. Since 2006, she has worked with numerous biopharmaceutical companies, clinical research organizations, and universities in the United States and Europe.

Data earned her bachelor’s degree from Purdue University in 1966, her medical degree from Washington University in 1970, and her doctorate in pharmacology from Vanderbilt University in 1977. She completed her internship and residency in internal medicine at the State University of New York at Buffalo from 1970 to 1973. While pursuing her doctorate at Vanderbilt, she completed a fellowship in clinical pharmacology and then was an instructor of medicine and pharmacology.

A member of the Washington University School of Medicine National Council, Data is active in several medical societies, including the American Society for Clinical Pharmacology (ASCPT), of which she was president in 1994. The author of numerous articles in peer-reviewed scientific publications, she recently completed a chapter for a textbook on clinical and translational science. She was elected to Who’s Who in American Women and received the Henry F. Elliott Distinguished Service Award from ASCPT in 2003.

Data and her husband, Herman Cantrell, live in Sparta, Tennessee.

[ Top ] [ Back to Honorees Page ]


Holloway

Jan Holloway, MS ‘83

Community Leader

Jan Holloway is an accomplished corporate and community leader and a strong advocate for women.

Holloway formerly served as senior vice president, chief of staff and community relations for Monsanto Co. She joined Monsanto in 1984 and held a variety of positions in the information technology organization, including chief information officer. Prior to beginning her career at Monsanto, she was a staff research associate at Washington University’s Center for Air Pollution Impact and Trend Analysis.

A dedicated and active alumna, Holloway is a member of the McKelvey School of Engineering National Council. She also co-chairs the university’s Women & Engineering Initiative with Michele Liebman. The engineering school launched this program as a vehicle for engineering alumnae to support each other, mentor female students, and promote STEM education to female students of all ages. Holloway and Liebman established the first Women & Engineering Challenge Fund to inspire other alumni and friends to support diversity, help foster a strong community to enhance the experience of female students during their time on campus, and provide additional opportunities for their development and growth. The school honored Holloway with an Alumni Achievement Award in 2010 and the Dean’s Award in 2018.

The greater St. Louis community has widely recognized Holloway for her exemplary leadership. She has been named a St. Louis Business Journal Most Influential Business Woman, YWCA Leader of Distinction, 100 Corporate Women Leaders in STEM, Greater Missouri Community Leader of the Year, and Urban League Corporate Leadership Honoree. Holloway currently serves on the boards of Raven Industries, Cortex Innovation Community, Technology Entrepreneur Center (T-Rex), Nine Network of Public Media, and United Way of Greater St. Louis.

Holloway earned a bachelor’s degree in mathematics from Augusta University in Augusta, Georgia, and a master’s degree in applied mathematics and computer science from Washington University.

A St. Louis resident, Holloway has a son, Alex, and a daughter, Kate.


Paul KochRoger Koch  

Paul Koch, BSBA,’61, JD ’64, MBA ’68

Co-Chairman
KOCH DEVELOPMENT COMPANY


​Roger L. Koch, BSBA ’64, MBA ’66

Co-Chairman
KOCH DEVELOPMENT COMPANY



Paul and Roger Koch are co-chairmen of the board of Koch Development Co., a third-generation family-owned business that develops, owns, and manages commercial real estate and entertainment attractions in St. Louis and other national markets.

Paul and Roger each have more than 50 years of entrepreneurial experience in real estate. They began their careers building homes, developing residential subdivisions, and buying and managing apartments. In the 1990s, they shifted focus to commercial real estate, ultimately investing in more than one million square feet of office, industrial, retail, and warehouse space. They further expanded their portfolio in 2011 when they ventured into entertainment properties. Today, Koch Development owns and operates SkyWheel observation wheels in Myrtle Beach, South Carolina, and Panama City Beach, Florida, with additional wheels coming soon.

Both brothers attended Washington University and proudly served their country. After earning his bachelor’s and law degrees, Paul was a judge advocate and trial attorney in the U.S. Air Force for three years. He then returned to St. Louis and completed his MBA at Olin Business School. Roger also earned his bachelor’s degree and MBA at the university and finished four years of military service as a logistics auditor in the Air Force.

The Koch family has a long history of philanthropy at Washington University. Dedicated to raising awareness about the complexities of family businesses and improving the success and longevity of these enterprises, Paul and his wife, Elke, and Roger and his wife, Fran, made a commitment to establish the Koch Center for Family Business at Olin Business School in 2018. Through research, education, and outreach, the Koch Center strives to increase academic knowledge of family businesses, prepare the next generation of family business leaders for success, and provide educational resources to the greater family business community.

In addition, the Kochs have established two distinguished professorships, one affiliated with the Koch Center at Olin and one at the School of Law. They also have provided generous support for the Alvin J. Siteman Cancer Center, the law school, and Olin Business School. Roger and Paul received Distinguished Alumni Awards from Olin in 2012. Paul was a 2018 recipient of a Distinguished Alumni Award from the School of Law.

Paul and Roger are dedicated business and civic leaders. A former municipal judge, Paul has served on the St. Louis County Charter Commission, as chairman of the board of the American Cancer Society’s Missouri division, and as president of the Homebuilders Association of Eastern Missouri. Roger has been a member of the boards of Crossroads College Preparatory School, Optimist International Foundation, and Archways, a chemical dependency rehabilitation center formerly located in St. Louis, and Purnell School in Pottersville, New Jersey. He and Fran are active in their church, having served in a variety of leadership positions. Both brothers are former board chairmen of Mark Twain South County Bank and past board members of Mark Twain St. Louis Bank.

Paul and Elke live in St. Louis and have two children and four grandchildren. Passionate about the outdoors and fly-fishing, they have traveled worldwide in pursuit of both freshwater and saltwater trout.

An avid boater, Roger has successfully traversed the Great Loop, a continuous waterway that allows recreational mariners to explore eastern North America. He and Fran split their time between St. Louis and Naples, Florida. They have two children and four grandchildren.


Steve Miller

Steve Miller, HS '91, MBA '02

Executive Vice President & Chief Clinical Officer
CIGNA CORPORATION

A nationally recognized advocate for greater access, affordability, and excellence in health care, Steve Miller has extensive experience as a medical researcher, clinician, and administrator. As chief clinical officer at Cigna Corp., he leads the company’s clinical policy, quality, and performance efforts. He was appointed to the position in December 2018 when Cigna acquired Express Scripts.

Miller formerly served as Express Scripts’ senior vice president and chief medical officer. In this position, he was responsible for supporting government relations, leading the pharmacy and therapeutics committee, managing the medical affairs team, and interfacing with client groups. During his 12 years in the role, Miller focused on improving health outcomes and value through electronic prescribing initiatives, specialty solutions, and overall product development.

Prior to joining Express Scripts, Miller was vice president and chief medical officer at Barnes-Jewish Hospital, where he oversaw oncology services, radiation oncology, graduate medical education, international health, research affairs, patient safety and quality, marketing and communications, physician services, and employed physicians.

Miller earned his MBA from Washington University’s Olin Business School. He believes this degree, in combination with his medical degree and clinical and research experiences, has allowed him to have a more significant impact as a health-care administrator. A member of the Olin Business School National Council, he was a 2015 recipient of Olin’s Distinguished Alumni Award.

After graduating from the University of Missouri-Kansas City School of Medicine in 1983, he completed a residency in medicine at the University of Colorado. He then trained as a fellow in nephrology at Washington University School of Medicine. The author of more than 80 scientific articles, Miller has been recognized for his research in the areas of acute renal failure, hypertension, and health-care economics.

Miller lives in St. Louis with his wife, Vicky Fraser, MD, the Adolphus Busch Professor of Medicine and head of the Department of Medicine at Washington University School of Medicine. They have three adult children.


Stephen Sands

Stephen Sands, BS ’79, MS ’79

Vice Chairman of Investment Banking & Chairman of Global Healthcare Group
LAZARD​​

Stephen Sands has built a 25-year career providing strategic and financial advice to senior executives and boards of directors at leading health-care and life sciences companies across the globe. He is vice chairman of investment banking and chairman of the Global Healthcare Group at Lazard, a financial advisory and asset management firm.

Prior to joining Lazard, Sands was a partner in the health-care practice of McKinsey & Company. He co-founded two biotechnology companies, Enzytech and Opta Food Ingredients. The former was acquired by Alkermes and the latter by Stake Technology. He currently is a director on the boards of Cognition Therapeutics, a biopharmaceutical company pioneering innovative therapies for Alzheimer’s disease and other neurocognitive disorders, and Cytosite Biopharma, which is developing precision imaging products that determine a cancer patient’s early response to immunotherapy.

Sands is a frequent keynote speaker and panelist at biopharmaceutical and health-care industry events. In 2008, he received the New York Biotechnology Association’s inaugural The Cures Start Here Business Leader of the Year Award.

A dedicated alumni leader, Sands is a member of the McKelvey School of Engineering National Council and the New York Regional Cabinet. He and his wife, Maxine, have given generously to the engineering school, making an estate commitment to establish the Stephen and Maxine Sands Professorship in Engineering, creating an endowed scholarship fund, and providing ongoing support for annual scholarships and entrepreneurship programs. In 2014, the engineering school recognized him with an Alumni Achievement Award.

Passionate about STEM education, Sands is a trustee and co-chair of the nominating and governance committee of the New York Hall of Science and is a member of the Rockefeller University Council, the Columbia University Science Advisory Committee, and the Rand Corporation Health Board of Advisors.

Sands earned a bachelor’s degree in biology from Oberlin College, bachelor’s and master’s degrees in chemical engineering from Washington University, and an MBA from New York University.

The Sands family lives in New York City. Stephen and Maxine have two sons, Adam and Joshua, and a daughter, Casey. Joshua completed a post-baccalaureate premedical program at Washington University in 2018. Also a WashU graduate, Casey earned a bachelor’s degree in systems science and engineering in 2017. 


[ Top ] [ Back to Honorees Page ]


Anthony Thompson 

Anthony Thompson, MS ’99

Chairman & CEO
KWAME BUILDING GROUP INC.

Tony Thompson is president and chief executive officer of Kwame Building Group Inc., which he founded in 1991. Headquartered in St. Louis with offices in eight states, Kwame has been widely recognized as a leading construction management firm. The company’s projects span the private and public sectors and include educational facilities, major airports, light-rail systems, hospitals, wastewater treatment plants, and government buildings.

Prior to starting Kwame, Thompson worked for Monsanto Co., the Army Corps of Engineers, and Anheuser-Busch Cos., serving in engineering roles. He is active in several professional organizations, including the Construction Management Association of America, the Association of General Contractors, and the St. Louis Council of Construction Consumers.

A native St. Louisan, Thompson originally planned to study music in college. Although he was awarded a scholarship for that purpose, he ultimately chose to pursue bachelor’s degrees in architectural engineering and in environmental design at the University of Kansas, graduating in 1983. He later earned an MBA from Webster University and a master’s degree in civil engineering from Washington University.

Following his parents’ example, Thompson is dedicated to giving back to his community. The Kwame Foundation, his company’s philanthropic arm, supports education and mentorship opportunities for promising young people with a focus on minority and first-generation college students. Thompson has endowed two scholarships at Washington University, one in the McKelvey School of Engineering in memory of his brother and another at the medical school to honor his mother, former state Rep. Betty L. Thompson.

Committed to advancing the St. Louis region, Thompson generously shares his time and talents with local nonprofit organizations and institutions. He is a long-term member of the St. Louis Regional Business Council and serves on the boards of the St. Louis Police Foundation and Maryville University. A former member of the Barnes-Jewish Hospital board and the university’s Gephardt Institute National Council, Thompson has served on the McKelvey School of Engineering National Council since 2012. His many accolades as a business and community leader include a 2004 Alumni Achievement Award from McKelvey Engineering.

Thompson and his wife, Kim, reside in Chesterfield, Missouri. They have a son, Michael, and a daughter, Kristin.

      [ Top ] [ Back to Honorees Page ]


Distinguished Faculty Award Honorees


Guy GeninGuy M. Genin

Harold and Kathleen Faught Professor of Mechanical Engineering
MCKELVEY SCHOOL OF ENGINEERING

An internationally recognized expert in mechanobiology, Guy Genin studies interfaces and adhesion in nature, physiology, and engineering. His research aims to understand and harness the role of force in living systems. Through these efforts, Genin and his group are working to advance path-breaking solutions, including engineered scaffolds for tissue repair and regeneration, improved reconstructive surgery, therapy for tissue inflammation and fibrosis, hardier crops that require fewer resources, and more.

Genin is a faculty member in the departments of Mechanical Engineering & Materials Science and Biomedical Engineering in the McKelvey School of Engineering and the Department of Neurosurgery in the School of Medicine. He is the McDonnell International Scholars Academy Ambassador to Xi'an Jiaotong University in China, where he serves as the Thousand Talents Plan Professor of Life Sciences. Genin co-directs the Center for Engineering Mechanobiology, a Science and Technology Center funded by the National Science Foundation and housed at Washington University and the University of Pennsylvania, with several other satellite locations. He is also chief engineer for the university's Center for Innovation in Neuroscience and Technology and is active in several start-ups.

A fellow of the American Society of Mechanical Engineers (ASME) and the American Institute for Medical and Biological Engineering, Genin has served on the editorial boards of numerous journals. He co-chairs the working group on integrated multiscale biomechanics experiment and modeling for the Interagency Modeling and Analysis Group of the National Institutes of Health (NIH).

Genin is the recipient of numerous awards for engineering design, teaching, and research, including a Research Career Award from NIH; the Skalak Medal from ASME; the Changjiang Scholar Award from the Chinese Ministry of Education; the Northcutt-Coil Professor of the Year Award from the McKelvey School of Engineering; and Professor of the Year from the Washington University Student Union.

Genin joined the Washington University faculty in 1999. He earned a bachelor’s and a master’s degree from Case Western Reserve University and a master’s degree and doctorate in applied mechanics and solid mechanics from Harvard University. He completed postdoctoral training at Cambridge and Brown universities.

Genin and his wife, Li Zou, have two sons.


 Jeffrey Milbrandt

Jeffrey Milbrandt, MD ’78

James S. McDonnell Professor and Head of the Department of Genetics and Executive Director of the McDonnell Genome Institute
SCHOOL OF MEDICINE

Jeffrey Milbrandt is widely recognized for discovering fundamental genetic mechanisms that have led to potential therapeutic interventions for neurodegenerative conditions such as Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease.

As the James S. McDonnell Professor and head of the Department of Genetics and executive director of the McDonnell Genome Institute, Milbrandt brings strength in basic and translational science and vast knowledge of the expanding role of genetics in the diagnosis, prognosis, and treatment of disease. Under his leadership, the Department of Genetics has focused on disease-based genetic research and helped the School of Medicine become an international leader in precision medicine and genome engineering. He is leading the McDonnell Genome Institute into a new era of using genomics to uncover mechanisms of human disease and developing novel genomic technologies to identify new therapeutic targets. 

Milbrandt and his colleague Aaron DiAntonio, the Alan A. and Edith L. Wolff Professor of Developmental Biology, are founding directors of the Needleman Center for Neurometabolism and Axonal Therapeutics, which seeks to understand the influence of metabolism on neurodegenerative diseases in order to identify new treatments for these disorders. He was actively involved in establishing the Hope Center for Neurological Disorders, which is dedicated to supporting research that uncovers molecular mechanisms that contribute to neurodegenerative conditions.

After completing his medical degree from Washington University School of Medicine in 1978, Milbrandt earned his doctoral degree and completed residency training in pathology at the University of Virginia. He has devoted his career to the School of Medicine, where he joined the faculty in 1983 as an assistant professor of pathology and medicine. He became the David Clayson Professor of Neurology in 2005, head of the Department of Genetics in 2009, executive director of the McDonnell Genome Institute in 2018, and co-director of the Needleman Center in 2018. He also serves as professor of pathology and immunology, internal medicine, and neurology.

Milbrandt received the Washington University Alumni Faculty Award in 1998 and the School of Medicine’s 2nd Century Award in 2018. He has co-authored over 250 publications and holds more than 25 patents on neurotrophic factors and axonal protective agents and their use in treating neurological disorders.

Milbrandt and his wife, Beth, have three children: Nicole, Joshua, and Melissa.


Tamanaha

Brian Z. Tamanaha

John S. Lehmann University Professor
SCHOOL OF LAW


Brian Tamanaha is an internationally renowned legal theorist and law and society scholar. The author of nine books and more than 50 articles, he has written extensively on the rule of law and on law and development. Tamanaha has developed a social scientific theoretical account of law as a complex of institutions that evolve over time in connection with social, economic, political, technological, and ecological changes. He has delivered dozens of keynote speeches around the globe, and his books have received six international awards. Most recently, A Realistic Theory of Law (2017) won the 2019 IVR Book Prize from the International Association for Philosophy of Law and Social Philosophy for best book in legal philosophy published between 2016 and 2018.

After 15 years at St. John’s University School of Law in New York City, Tamanaha joined the faculty of Washington University School of Law in 2010. Students at both law schools have voted him professor of the year. His concern for law graduates and law schools motivated him to write Failing Law Schools (2012), a critical examination of legal education. Controversial among legal academics, the book elicited strong support from some and sharp criticism from others. The American Bar Association invited Tamanaha to address a plenary session of its 2013 meeting to discuss the issues raised in the book. A poll of over 300 deans and law professors conducted by National Jurist named him the most influential legal educator in 2013.

Before embarking on his academic career, Tamanaha served for two years as an Assistant Attorney General in Yap, of the Federated States of Micronesia, and served as legal counsel at the 1990 Micronesian Constitutional Convention.  Prior to working in Yap, he was an Assistant Federal Public Defender in Hawaii for two years.

Tamanaha grew up in Hawaii and aspired to be a surfer until he realized it would be difficult to make a living through the sport. He earned a bachelor’s degree from the University of Oregon, a law degree from Boston University, and a doctorate of juridical science from Harvard Law School.

He and his wife, Honorata, have three daughters, Jolijt, AB ’15, Kats, and Sava, and a son, Vincent.


Vetta Thompson

Vetta L. Sanders Thompson

E. Desmond Lee Professor of Racial and Ethnic Diversity​
BROWN SCHOOL

 

Vetta Sanders Thompson is a noted expert in the areas of racial identity, psychosocial implications of race and ethnicity in health behavior, and sociocultural determinants of health and mental health disparities. Her goal is to empower racial minority communities, particularly the African-American community, to improve health and well-being. She has a history of funded research addressing community engagement and the promotion of cancer screening among African Americans. Made possible through a grant from the Patient-Centered Outcomes Research Institute, her current project entails developing a measure of the quality of community- and patient-engaged research.

A licensed clinical psychologist and health service provider in the state of Missouri, Sanders Thompson joined the faculty of the Brown School in 2008. She serves as the school’s associate dean of diversity, equity, and inclusion and as co-director of the Center for Community Health Partnership and Research at the university’s Institute for Public Health. She also is a faculty affiliate of the Department of African and African-American Studies as well as the Interdisciplinary Program in Urban Studies, both in Arts & Sciences. She teaches courses in human diversity, health disparities, and evidence-based treatments in mental health. 

Sanders Thompson earned a bachelor’s degree in psychology and social relations from Harvard University in 1981. She earned a master’s degree and doctorate in psychology, completing the clinical training program, from Duke University in 1984 and 1988, respectively. 

Active in numerous professional associations, Sanders Thompson is a member of the Missouri Psychological Association and the American Psychological Association and served as an associate editor for the journal PsycCritiques. She is a past chair of the State Committee of Psychologists and a past president of the Missouri Psychological Association. Over the years, she has been honored by the St. Louis community as well as her professional colleagues. Her many accolades include the 2018 Terry Leet Researcher of the Year Award from Generate Health, the 2017 Dr. Richard R. Wilkerson Lifetime Achievement Award from the Missouri Psychological Association, and Mental Health America of Eastern Missouri’s Silver Key Award.

[ Top ] [ Back to Honorees Page ]

 


Robert Brookings Awards Honorees


Needleman

Philip and Sima K. Needleman


Philip and Sima Needleman have demonstrated an exceptional dedication to Washington University, an institution that has shaped their careers and lives.

Phil began hi​s long and distinguished scientific career in 1964 as a postdoctoral fellow at Washington University. He later joined the faculty of the Department of Pharmacology, serving as chair from 1976 to 1989. Widely recognized for his research on hypertension, he and his colleagues discovered the first angiotensin antagonist and atrial natriuretic factor, a cardiac hormone.

Separately, his lab discovered COX-2, an enzyme responsible for inflammation and pain in arthritis patients. After accepting a position as chief scientist with St. Louis-based Monsanto in 1989, Phil led the development of the arthritis medication Celebrex, which inhibits COX-2. Approved by the FDA in 1998, the blockbuster anti-inflammatory drug has been used by millions of Americans.

After earning a master’s degree in social work from the Brown School, Sima worked as a medical social worker at The Jewish Hospital of St. Louis before its merger with Barnes Hospital. She began in the obstetrics department and later joined the staff of the in vitro fertilization (IVF) program. The program was the first to successfully perform IVF in Missouri, and Sima and her colleagues were among the vanguard in their work with IVF patients. She went on to open a private practice.

Both Phil and Sima remain active in the Washington University community. An emeritus trustee, Phil chairs the School of Medicine National Council. A five-time recipient of Washington University’s Distinguished Faculty Award, he also received the School of Medicine’s 2nd Century Award in 1994 and an honorary doctorate of science in 1999. Sima has served the Brown School in several volunteer leadership capacities, including as president of the alumni board and as a member of the National Council. In 2006, the Brown School honored her with its Dean’s Medal.

The Needlemans have generously supported the university, establishing three endowed scholarships at the Brown School and an endowed professorship, a pharmacology prize, and fellowships in regenerative medicine at the School of Medicine. In 2018, they made a catalytic gift to create two centers of excellence to develop therapies for chronic diseases of aging and neurodegeneration. In 2011, the couple was honored with the Eliot Society’s Search Award, which is bestowed upon members of the university community who have made exceptional contributions to furthering its mission.

The Needlemans live in St. Louis. Their daughter, Nina, AB ’82, MBA ’88, and son, Lawrence, AB ’85, are alumni of the university.

[ Top ] [ Back to Honorees Page ]


Rodger and Paula Riney

Rodger and Paula Riney

 

Through their generous philanthropy and leadership, Rodger and Paula Riney have demonstrated a commitment to advancing human health for future generations.

Rodger grew up in Kirkwood, Missouri, and earned a bachelor’s degree in civil engineering and an MBA from the University of Missouri-Columbia. In 1969, he joined Edward D. Jones & Co. in St. Louis and later became a partner.

Paula was born in Oklahoma City and lived in 10 locales as her father pursued his Navy career around the United States and Taiwan. His last assignment was in St. Louis, where Paula met Rodger in 1977. They were married two years later.

In 1980, Rodger left Edward Jones to enter the relatively new discount brokerage industry by starting Scottrade. Over the years, the firm opened 500 branch offices and became one of the largest online trading firms. Scottrade won the J.D. Power award for highest online investing satisfaction 11 times and was included on Fortune’s “100 Best Places to Work For” list six times. 

In October 2015, Rodger was diagnosed with multiple myeloma and sought treatment from Washington University physicians at the Alvin J. Siteman Cancer Center. While treatment options and life expectancy for those facing multiple myeloma have improved in recent years, there is no cure for the blood cancer.

About six months after his diagnosis, in response to his uncertain health, Rodger decided to examine strategic alternatives for Scottrade. Five months later, the company announced it would be acquired by TD Ameritrade. The sale was completed in September 2017.

Paula and Rodger’s philanthropy began in 1991 when Rodger’s mother succumbed to Alzheimer’s disease. Paula’s father, who also struggled with Alzheimer’s, died in 2012. Less than a year later, her mother died following a long battle with Parkinson’s disease. The Rineys’ experience with these two neurodegenerative disorders and multiple myeloma sparked in them a heartfelt desire to help others facing similar circumstances. Toward that end, they have provided significant resources to Washington University School of Medicine and Siteman Cancer Center to accelerate the efforts of physicians and scientists working to advance cutting-edge treatments for the diseases.

A member of the School of Medicine National Council, Rodger also serves on the boards of the Alzheimer’s Association Greater Missouri Chapter, BioSTL, and the Multiple Myeloma Research Foundation.

The couple has a daughter, two sons, and six grandchildren. One of their sons, Michael, BSBA ’08, is an alumnus of the university.

© , Washington University in St. Louis, MSC 1210, One Brookings Drive, St. Louis, MO 63130

Terms and Conditions